|Dr. Vijai Kumar, M.D.|
|President and Chief Medical Officer|
Dr. Vijai Kumar has over 40 years of experience in Global Drug Development, Strategic Relationship Building, Business Development and various other aspects of clinical research and the pharmaceutical industry. He is responsible for starting the concept of site management organizations in Asia. Prior to that, Dr Kumar worked as President and CEO, Neeman Medical International and as Medical Director, Sandoz and Regional Director, Asia for The Upjohn Company, where he was responsible for contributing to more than 25 NDA submissions. Dr. Kumar has experience as a clinician, investigator, pharmaceutical physician, consultant and service provider. He has served as a Member of the expert committee constituted by the Drugs Controller General (India) to develop GCP Guidelines in India and as a member of the Board of Governors for the Institute of Clinical Research, India. Dr Kumar has personally been involved in the conduct of over 200 clinical trials in various therapeutic areas such as, Infectious Disease, Neuropsychiatry, Cardiovascular Disorders, Metabolism and Rheumatology, Ophthalmology in Asia, Europe and the USA and has presented numerous papers on various aspects of clinical research across the globe. Dr Kumar holds an M.D. in Internal Medicine and an M.B.B.S. from Armed Forces Medical College, Pune.
Dr. Kumar was recently recognized by an audience of his peers as a most inspiring leader in the drug development and life sciences industry. Dr. Kumar's long time passion, dedication and contributions to clinical research were highlighted in a special profile within the PharmaVoice Magazine special issue -"100 of the Most Inspiring People". He was featured in a dedicated profile within the magazine in a section titled "The Clinical Specialists" Dr. Kumar is the Advisory Board member of Life Science World.
|Dr. Saurendra Das, M.D.|
Dr. Das has over 14 years of experience in coordination of all phases of global and domestic clinical trials. Prior to joining Excel Life Sciences, Dr. Das was personally responsible for establishing two major SMOs and one CRO in India. He has led large clinical operations teams and brought many innovations to the field including strategies, systems and processes for faster enrollment and increased retention. Dr. Das has vast experience includes designing and reviewing clinical trial related SOPs and WPDs, designing SOPs for Ethics Committees, budgeting for clinical trials and setting up of central pharmacies. He managed the clinical trials at two sites that successfully passed the first US FDA inspection in India and also managed clinical trials at two sites that successfully passes the EMI inspection . As an active trainer, he worked closely with faculty from Harvard Medical International developing a global training program and has personally trained more then a thousand professionals of pharma, CRO, SMO, Central lab and sites in ICH-GCP and clinical research. Dr Das has worked on the faculty of the CDSCO, WHO and ICRI. Dr. Das holds an M.D. in clinical pharmacology from M. K. C. G. Medical College in Odisha, India.
|Founder, Chief Operating Officer|
Mohit was most recently the General Manager, New Product and Platforms for American Express where he led a global servicing team based out of the US, Canada and India. Previously, he was the Co-Founder and Interim Chief Executive Officer of Workadia , a joint venture between American Express, TIBCO, Infosys and Westbridge Capital. Before Workadia, Mohit had been at American Express for over 10 years, most recently as Vice President in its Interactive Business Development group, where along with shaping American Express' E-Commerce strategy, he was the founding member and business leader for Workadia, which was spun off from within American Express. His collaboration with startups, now highly successful public online travel companies, played a key role in transforming the corporate travel industry from a manual labor-intensive operation to an online, highly automated and efficient industry.
His experience in leveraging technology and labor arbitrage to reduce operating costs and accelerate product development led him to found Excel Life Sciences, which helps customers accelerate drug development and improves patient care and satisfaction, while lowering costs for pharmaceutical companies, hospitals and medical research organizations. In addition, Mohit also wants to focus on the humanitarian aspect of bringing leading lines of treatment to a patient population that does not necessarily have access to good healthcare. This humanitarian aspect is an integral part of the Excel Life Sciences mission. Mohit holds a Bachelor's degree in Business from University of Allahabad, India and a Master of Science from the University of Massachusetts, Amherst.
|Chief Financial Officer|
In the last 10 years, Carl has been the senior financial executive of a number of tech start-ups, either as the in-house CFO or a consulting CFO. These firms have been in a range of industries from consulting to software to opto-electronics and healthcare. Previously, Carl had spent over ten years in various financial and strategic roles in the US and Europe at Global 100 manufacturing firms. His roles included merger and acquisition due diligence on several transactions ranging from $10 to $300 million, developing the business case for a number of joint ventures, and subsequently moving two of those joint ventures from start-up to profitability as the financial executive. Carl holds a BA in Economics and an MBA Finance from the University of Illinois.